loading

Recent events

GLuna Shrimp owner Gabriel Luna

AdvertisementX
AdvertisementX

Companies

Benchmark’s new sea lice products gets Norwegian Medicines Agency green light

The aquaculture biotechnology company received marketing authorization from the Norwegian Medicines Agency for its new sea lice veterinary medicinal treatments in Norway

By Undercurrent News | July 5, 2021 09:55 BST
Credit: Benchmark Holdings
Related

Former US seafood market owner charged with killing $10,000 worth of lobsters

Credit: WoodysPhotos/Shutterstock.com

Western Norway suffers unusually high sea lice levels

Fish health firm launches bacteriophage to fight salmon skin disease

Canadian politician calls for mandatory insurance for fishery workers

free read Sea Watch closes doors of 100-year-old Maine seafood canning facility

McDonald’s Filet-O-Fish earns big smile from Trump

AdvertisementX

Aquaculture biotechnology company Benchmark has received marketing authorization from the Norwegian Medicines Agency for its new sea lice veterinary medicinal treatments in Norway [...]

Want to keep reading?

Sign up for a trial to have full access to our articles for 7 days!

Tradex: US state has ‘exceptional’ fall chum season after disappointing 2023

Canadian lobster dock prices high in advance of big openings

Aquaculture infra projects in Canadian province bag CAD 7.7m in funding

Grieg adds new executive member to Canadian operation

AdvertisementX

Stay on the pulse

Get recommendations, data, editor’s picks, and the latest news from around the seafood world straight to your inbox.

Select your interests

Please select at least one newsletter d indicates our daily newsletters | 2w indicates twice-weekly | All others sent weekly All briefings are sent weekly, unless otherwise indicated
Region
Breaking news
Jobs
Species
Topic

Fill in your details

Please select at least one newsletter!
  • (eg new industry reports, prices data)
  • (eg subscription or report early birds)
  • (eg advertising, trade shows news)
How we handle your data We never share, sell or distribute our subscribers’ data. You may at any time unsubsribe from our newsletters, and request that we erase all information stored about you. Please check our Privacy policy for more details.

We use MailChimp and HubSpot as our email campaign platforms. By subscribing, you agree that the information you provide will be transferred to MailChimp and HubSpot for processing in accordance with their privacy policies (MailChimp privacy policy, HubSpot privacy policy) and terms (MailChimp terms, HubSpot terms).

Thank you. Please check your inbox to confirm your selection and start receiving newsletters.

Cookies on Undercurrent News

We use cookies for performance, security and analytics. To stop seeing this banner click Accept, or select Manage cookies to set your preferences and privacy settings.